Cited by 8Systemic Lupus Erythematosus ResearchMachine Learning in HealthcareArtificial Intelligence in Healthcare

Prediction of Lupus Classification Criteria via Generative AI Medical Record Profiling

Open access
Nair, Sandeep, Lushington, Gerald H., Purushothaman, Mohan, Rubin, Bernard, Jupe, Eldon, Gattam, Santosh·2025·BioTech

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that poses serious long-term patient burdens. (1) Background: SLE patient classification and care are often complicated by case heterogeneity (diverse variations in symptoms and severity). Large language models (LLMs) and generative artificial intelligence (genAI) may mitigate this challenge by profiling medical records to assess key medical criteria. (2) Methods: To demonstrate genAI-based profiling, ACR (American College of Rheumatology) 1997 SLE classification criteria were used to define medically relevant LLM prompts. Records from 78 previously studied patients (45 classified as having SLE; 33 indeterminate or negative) were computationally profiled, via five genAI replicate runs. (3) Results: GenAI determinations of the “Discoid Rash” and “Pleuritis or Pericarditis” classification criteria yielded perfect concurrence with clinical classification, while some factors such as “Immunologic Disorder” (56% accuracy) were statistically unreliable. Compared to clinical classification, our genAI approach achieved a 72% predictive success rate. (4) Conclusions: GenAI classifications may prove sufficiently predictive to aid medical professionals in evaluating SLE patients and structuring care strategies. For individual criteria, accuracy seems to correlate inversely with complexities in clinical determination, implying that improvements in AI patient profiling tools may emerge from continued advances in clinical classification efficacy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biotech14010015

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Generative AI profiled medical records to clinically classify SLE on the basis of ACR 1997 criteria with high concurrence for the discoid rash criteria.

    “For example, Nair et al (2025) profiled medical records with generative AI to clinically classify SLE on the basis of American College of Rheumatology (ACR) 1997 criteria with high concurrence for the “discoid rash” criteria.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. [1]Murimi-Worstell I.B. Lin D.H. Nab H. Kan H.J. Onasanya O. Tierce J.C. Wang X. Desta B. Alexander G.C. Hammond E.R. Association between organ damage and mortality in systemic lupus erythematosus: A systematic review and meta-analysis BMJ Open 2020 10 e031850 10.1136/bmjopen-2019-031850 32444429 PMC7247371 · DOI
  2. [2]Izmirly P.M. Parton H. Wang L. McCune W.J. Lim S.S. Drenkard C. Ferucci E.D. Dall’Era M. Gordon C. Helmick C.G. Prevalence of Systemic Lupus Erythematosus in the United States: Estimates from a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Registries Arthritis Rheumatol. 2021 73 991 996 10.1002/art.41632 33474834 PMC8169527 · DOI
  3. [3]Kariburyo F. Xie L. Sah J. Li N. Lofland J.H. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States J. Med. Econ. 2020 23 1 9 10.1080/13696998.2019.1678170 31589081 · DOI
  4. [4]Buie J. McMillan E. Kirby J. Cardenas L.A. Eftekhari S. Feldman C.H. Gawuga C. Knight A.M. Lim S.S. McCalla S. Disparities in Lupus and the Role of Social Determinants of Health: Current State of Knowledge and Directions for Future Research ACR Open Rheumatol. 2023 5 454 464 10.1002/acr2.11590 37531095 PMC10502817 · DOI
  5. [5]Kernder A. Richter J.G. Fischer-Betz R. Winkler-Rohlfing B. Brinks R. Aringer M. Schneider M. Chehab G. Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort Lupus 2021 30 431 438 10.1177/0961203320983445 33402036 PMC7933718 · DOI
  6. [6]Bruce I.N. Buie J. Bloch L. Bae S.C. Costenbader K. Levy R.A. Werth V.P. Marion A. Sangodkar S. Manzi S. Lupus spectrum ambiguity has long-term negative implications for patients Lupus Sci. Med. 2023 10 e000856 10.1136/lupus-2022-000856 37534513 PMC9835935 · DOI
  7. [7]Adamichou C. Bertsias G. Flares in systemic lupus erythematosus: Diagnosis, risk factors and preventive strategies Mediterr. J. Rheumatol. 2017 28 4 12 10.31138/mjr.28.1.4 32185248 PMC7045928 · DOI
  8. [8]Katarzyna P.B. Wiktor S. Ewa D. Piotr L. Current treatment of systemic lupus erythematosus: A clinician’s perspective Rheumatol. Int. 2023 43 1395 1407 10.1007/s00296-023-05306-5 37171669 PMC10261264 · DOI
  9. [9]Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum. 1997 40 1725 10.1002/art.1780400928 9324032 · DOI · Paper page
  10. [11]Petri M. Orbai A.M. Alarcón G.S. Gordon C. Merrill J.T. Fortin P.R. Bruce I.N. Isenberg D. Wallace D.J. Nived O. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus Arthritis Rheum. 2012 64 2677 2686 10.1002/art.34473 22553077 PMC3409311 · DOI · Paper page
  11. [12]Morgan C. Bland A.R. Maker C. Dunnage J. Bruce I.N. Individuals living with lupus: Findings from the LUPUS UK Members Survey 2014 Lupus 2018 27 681 687 10.1177/0961203317749746 29310537 PMC5888773 · DOI
  12. [14]Felten R. Sagez F. Gavand P.E. Martin T. Korganow A.S. Sordet C. Javier R.M. Soulas-Sprauel P. Rivière M. Scher F. Arnaud L 10 most important contemporary challenges in the management of SLE Lupus Sci. Med. 2019 6 e000303 10.1136/lupus-2018-000303 30729019 PMC6340557 · DOI
  13. [15]Kim J.W. Kim H.A. Suh C.H. Jung J.Y. Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus Front. Med. 2022 9 906475 10.3389/fmed.2022.906475 36035435 PMC9402996 · DOI
  14. [16]Jung J.Y. Suh C.H. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare Korean J. Intern. Med. 2017 32 429 438 10.3904/kjim.2016.234 28490724 PMC5432804 · DOI
  15. [17]Corbin D. Christian L. Rapp C.M. Liu L. Rohan C.A. Travers J.B. New concepts on abnormal UV reactions in systemic lupus erythematosus and a screening tool for assessment of photosensitivity Skin. Res. Technol. 2023 29 e13247 10.1111/srt.13247 36973991 PMC10059080 · DOI
  16. [18]Piga M. Arnaud L. The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand? J. Clin. Med. 2021 10 243 10.3390/jcm10020243 33440874 PMC7827672 · DOI · Paper page
  17. [19]Sciascia S. Radin M. Roccatello D. Sanna G. Bertolaccini M.L. Recent advances in the management of systemic lupus erythematosus F1000Research 2018 7 F1000 Faculty Rev-970 10.12688/f1000research.13941.1 30026918 PMC6039948 · DOI
  18. [20]Gladman D.D. Ibañez D. Urowitz M.B. Systemic lupus erythematosus disease activity index 2000 J. Rheumatol. 2002 29 288 291 11838846
  19. [21]Isenberg D.A. Rahman A. Allen E. Farewell V. Akil M. Bruce I.N. D’Cruz D. Griffiths B. Khamashta M. Maddison P. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus erythematosus Rheumatology 2005 44 902 906 10.1093/rheumatology/keh624 15814577 · DOI
  20. [22]Wallace D.J. Stohl W. Furie R.A. Lisse J.R. McKay J.D. Merrill J.T. Petri M.A. Ginzler E.M. Chatham W.W. McCune W.J. A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus Arthritis Rheum. 2009 61 1168 1178 10.1002/art.24699 19714604 PMC2758229 · DOI
  21. [23]Petri M.A. Merrill J.T. Maciuca R. Davis J.C. Jr. Kennedy W. FRI0293 Validation of the revised selena flare index in systemic lupus erythematosus Ann. Rheum. Dis. 2013 72 A473 A474 10.1136/annrheumdis-2013-eular.1420 · DOI
  22. [24]Ahsan M.M. Luna S.A. Siddique Z. Machine-Learning-Based Disease Diagnosis: A Comprehensive Review Healthcare 2022 10 541 10.3390/healthcare10030541 35327018 PMC8950225 · DOI · Paper page
  23. [25]Alowais S.A. Alghamdi S.S. Alsuhebany N. Alqahtani T. Alshaya A.I. Almohareb S.N. Aldairem A. Alrashed M. Bin Saleh K. Badreldin H.A. Revolutionizing healthcare: The role of artificial intelligence in clinical practice BMC Med. Educ. 2023 23 689 10.1186/s12909-023-04698-z 37740191 PMC10517477 · DOI · Paper page
  24. [26]Sistaninejhad B. Rasi H. Nayeri P. A Review Paper about Deep Learning for Medical Image Analysis Comput. Math. Methods Med. 2023 2023 7091301 10.1155/2023/7091301 37284172 PMC10241570 · DOI
  25. [30]Hersh W. Fultz Hollis K. Results and implications for generative AI in a large introductory biomedical and health informatics course NPJ Digit. Med. 2024 7 247 10.1038/s41746-024-01251-0 39271955 PMC11399285 · DOI
  26. [31]Magalhães Araujo S. Cruz-Correia R. Incorporating ChatGPT in Medical Informatics Education: Mixed Methods Study on Student Perceptions and Experiential Integration Proposals JMIR Med. Educ. 2024 10 e51151 10.2196/51151 38506920 PMC10993110 · DOI · Paper page
  27. [32]Yim D. Khuntia J. Parameswaran V. Meyers A. Preliminary Evidence of the Use of Generative AI in Health Care Clinical Services: Systematic Narrative Review JMIR Med. Inform. 2024 12 e52073 10.2196/52073 38506918 PMC10993141 · DOI
  28. [34]Qu Y. Nathaniel J. Li S. Gentine P. Deep Generative Data Assimilation in Multimodal Setting Proceedings of the 2024 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW) Seattle, WA, USA 17–21 June 2024 449 459 10.1109/CVPRW63382.2024.00050 · DOI
  29. [37]Stull C. Sprow G. Werth V.P. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist J. Rheumatol. 2023 50 27 35 10.3899/jrheum.220089 36109075 PMC10152495 · DOI
  30. [39]Sarkany R. I18. PHOTOSENSITIVITY: IS IT LUPUS? Rheumatology 2017 56 (Suppl. 2) kex060.018 10.1093/rheumatology/kex060.018 · DOI
  31. [41]Ceccarelli F. Govoni M. Piga M. Cassone G. Cantatore F.P. Olivieri G. Cauli A. Favalli E.G. Atzeni F. Gremese E. Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium J. Clin. Med. 2022 11 6016 10.3390/jcm11206016 36294337 PMC9604412 · DOI
  32. [42]Ryu S. Fu W. Petri M.A. Associates and predictors of pleurisy or pericarditis in SLE Lupus Sci. Med. 2017 4 e000221 10.1136/lupus-2017-000221 29118999 PMC5663266 · DOI
  33. [43]Wang S. Spielman A. Ginsberg M. Petri M. Rovin B.H. Buyon J. Broder A. Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria Clin. J. Am. Soc. Nephrol. 2022 17 1150 1158 10.2215/CJN.01280122 35882508 PMC9435982 · DOI
  34. [45]Krishnamurthy H. Yang Y. Song Q. Krishna K. Jayaraman V. Wang T. Bei K. Rajasekaran J.J. Evaluation of renal markers in systemic autoimmune diseases PLoS ONE 2023 18 e0278441 10.1371/journal.pone.0278441 37352246 PMC10289317 · DOI
  35. [48]van Beers J.J.B.C. Schreurs M.W.J. Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus J. Transl. Autoimmun. 2022 5 100155 10.1016/j.jtauto.2022.100155 35464346 PMC9026971 · DOI
  36. [49]Tsokos G.C. The immunology of systemic lupus erythematosus Nat. Immunol. 2024 25 1332 1343 10.1038/s41590-024-01898-7 39009839 · DOI
  37. [52]Mahara G. Tian C. Xu X. Wang W. Revolutionising health care: Exploring the latest advances in medical sciences J. Glob. Health 2023 13 03042 10.7189/jogh.13.03042 37539846 PMC10401902 · DOI
  38. [53]Lo M.S. Tsokos G.C. Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy Curr. Opin. Rheumatol. 2018 30 222 228 10.1097/BOR.0000000000000474 29206660 PMC6050980 · DOI
  39. [54]Basta F. Fasola F. Triantafyllias K. Schwarting A. Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New Rheumatol. Ther. 2020 7 433 446 10.1007/s40744-020-00212-9 32488652 PMC7410873 · DOI
  40. [55]Wamble D.E. Ciarametaro M. Dubois R. The Effect of Medical Technology Innovations on Patient Outcomes, 1990–2015: Results of a Physician Survey J. Manag. Care Spec. Pharm. 2019 25 66 71 10.18553/jmcp.2018.18083 29927346 PMC10398270 · DOI
  41. [56]Manca D.P. Do electronic medical records improve quality of care? Yes Can. Fam. Physician 2015 61 846 847 850–851 26472786 PMC4607324
  42. [57]Adler S. Effects of Poor Communication in Healthcare The HIPAA Journal 2024 Available online: https://www.hipaajournal.com/effects-of-poor-communication-in-healthcare/ (accessed on 23 December 2024)
  43. [58]Nijor S. Rallis G. Lad N. Gokcen E. Patient Safety Issues from Information Overload in Electronic Medical Records J. Patient Saf. 2022 18 e999 e1003 10.1097/PTS.0000000000001002 35985047 PMC9422765 · DOI · Paper page
  44. [60]Harishbhai Tilala M. Kumar Chenchala P. Choppadandi A. Kaur J. Naguri S. Saoji R. Devaguptapu B. Ethical Considerations in the Use of Artificial Intelligence and Machine Learning in Health Care: A Comprehensive Review Cureus 2024 16 e62443 10.7759/cureus.62443 39011215 PMC11249277 · DOI
  45. [61]Simmons A. Takkavatakarn K. McDougal M. Dilcher B. Pincavitch J. Meadows L. Kauffman J. Klang E. Wig R. Smith G. Benchmarking Large Language Models for Extraction of International Classification of Diseases Codes from Clinical Documentation medRxiv 2024 10.1101/2024.04.29.24306573 39608761 PMC12020521 · DOI
  46. [62]Gergianaki I. Bertsias G. Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner Front. Med. 2018 5 161 10.3389/fmed.2018.00161 29896474 PMC5986957 · DOI
  47. [63]Oglesby A. Korves C. Laliberté F. Dennis G. Rao S. Suthoff E.D. Wei R. Duh M.S. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes Appl. Health Econ. Health Policy. 2014 12 179 190 10.1007/s40258-014-0085-x 24573911 · DOI
  48. [65]Mohammed R.H. Bhutta B.S. Hand and Wrist Rheumatoid Arthritis. Updated 17 August 2023 StatPearls (Internet) StatPearls Publishing Treasure Island, FL, USA 2025 Available online: https://www.ncbi.nlm.nih.gov/books/NBK560890/ (accessed on 14 January 2025) 32809725
  49. [66]Santacruz J. Mantilla M. Pulido S. Isaza J.R. Tuta E. Agudelo C.A. Londono J. A Practical Overview of the Articular Manifestations of Systemic Lupus Erythematosus Cureus 2023 15 e44964 10.7759/cureus.44964 37822423 PMC10562134 · DOI
  50. [67]Du F. Qian W. Zhang X. Zhang L. Shang J. Prevalence of oral mucosal lesions in patients with systemic Lupus Erythematosus: A systematic review and meta-analysis BMC Oral. Health 2023 23 1030 10.1186/s12903-023-03783-5 38129844 PMC10734171 · DOI
  51. [68]de Arruda J.A.A. Villarroel-Dorrego M. Freire C.H. Molina-Ávila I. Pimentel-Solá J.M. Gilligan G. Piemonte E. Panico R. Panico J.C.R. Aranda-Romo S. Oral lesions of systemic lupus erythematosus: A collaborative Latin American study Lupus 2024 33 864 873 10.1177/09612033241252042 38686816 · DOI
  52. [69]Nico M.M. Vilela M.A. Rivitti E.A. Lourenço S.V. Oral lesions in lupus erythematosus: Correlation with cutaneous lesions Eur. J. Dermatol. 2008 18 376 381 Available online: https://www.researchgate.net/publication/5282125_Oral_lesions_in_lupus_erythematosus_Correlation_with_cutaneous_lesions (accessed on 4 January 2025) 18573706
  53. [70]Rodsaward P. Prueksrisakul T. Deekajorndech T. Edwards S.W. Beresford M.W. Chiewchengchol D. Oral Ulcers in Juvenile-Onset Systemic Lupus Erythematosus: A Review of the Literature Am. J. Clin. Dermatol. 2017 18 755 762 10.1007/s40257-017-0286-9 28477309 PMC5680373 · DOI
  54. [71]Takita H. Kabata D. Walston S.L. Tatekawa H. Saito K. Tsujimoto Y. Miki Y. Ueda D. Diagnostic Performance Comparison between Generative AI and Physicians: A Systematic Review and Meta-Analysis medRxiv 2024 10.1101/2024.01.20.24301563 PMC11929846 40121370 · DOI
  55. [72]Krusche M. Callhoff J. Knitza J. Ruffer N. Diagnostic accuracy of a large language model in rheumatology: Comparison of physician and ChatGPT-4 Rheumatol. Int. 2024 44 303 306 10.1007/s00296-023-05464-6 37742280 PMC10796566 · DOI · Paper page
  56. [73]Rodrigues Fonseca A. Felix Rodrigues M.C. Sztajnbok F.R. Gerardin Poirot Land M. Knupp Feitosa de Oliveira S. Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus Adv. Rheumatol. 2019 59 20 10.1186/s42358-019-0062-z 31092290 · DOI
  57. [74]Abdwani R. Al Masroori E. Abdullah E. Al Abrawi S. Al-Zakwani I. Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus Pediatr. Rheumatol. Online J. 2021 19 141 Erratum in Pediatr. Rheumatol. Online J. 2021, 19, 165. https://doi.org/10.1186/s12969-021-00655-6 10.1186/s12969-021-00619-w 34503539 PMC8428110 · DOI
  58. [75]Munroe M.E. Blankenship D. DeFreese D. Purushothaman M. DeJager W. Macwana S. Guthridge J.M. Kamp S. Redinger N. Aberle T. A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus Arthritis Rheumatol. 2023 75 723 735 10.1002/art.42389 36245261 PMC10106527 · DOI
  59. [76]Prieto Curiel R. Bishop S. A measure of the concentration of rare events Sci. Rep. 2016 6 32369 10.1038/srep32369 27577532 PMC5006036 · DOI
  60. [77]Patel A.U. Williams C.L. Hart S.N. Garcia C.A. Durant T.J.S. Cornish T.C. McClintock D.S. Cybersecurity and Information Assurance for the Clinical Laboratory J. Appl. Lab. Med. 2023 8 145 161 10.1093/jalm/jfac119 36610432 · DOI
  61. [78]Adnan M. Kutafina E. Beyan O. Cybersecurity Frameworks in Healthcare Data: Short Literature Review Stud. Health Technol. Inform. 2024 316 301 302 10.3233/SHTI240403 39176732 · DOI

Cited by

Sorted by citations

Authors
Nair, S., Lushington, G. H., Purushothaman, M., Rubin, B., Jupe, E., & Gattam, S.
Affiliations
Progentec Diagnostics, Inc., 755 Research Pkwy, Oklahoma City, OK 73104, USA
Corresponding author
Lushington, Gerald H.
Venue
BioTech
Publisher
MDPI AG
Published
2025-03-06
Volume
14
Issue
1
Pages
15
ISSN
2673-6284 (ISSN-L)
OpenAlex
W4408198517
Cited by
8
References
5
Citations by year
2026: 3 · 2025: 5
FWCI
5.84
Type
journal article
Language
en
Open access
Locations
  • BioTech (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
systemic lupus erythematosus, lupus classification criteria, generative AI, large language models, discoid rash, pleurisy, pericarditis, immune disorders, autoimmune disease diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review